Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 813

Bifidobacterium longum BORI

Intended Use: For use as an ingredient in powdered non-exempt term infant formula at up to 108 CFU per gram of powdered formula. Also for use in fermented milk; includes buttermilk and kefir; flavored milk beverages mixes, dried milk powder; imitation milk; yogurt; baby cereals and foods, powder form; meal replacement powder and nutrition drink mix powder; and sugar substitute, powder form at up to 109 CFU per serving.
Basis: Scientific procedures
Notifier: BIFICO CO., LTD
Notifier Address: 23-16 Nonggongdanji-gil
Hongcheon-eup, Hongcheon-gun
Gangwon-do, 25117
Republic of Korea
Date of filing: Jun 21, 2019
GRAS Notice (releasable information): GRN 813 with amendment (in PDF) (1.7 MB)
Date of closure: Jun 21, 2019
FDA's Letter: FDA has no questions (in PDF) (82 kB)
-
-